Application

14237905 · 4-(8-METHOXY-1-((1-METHOXYPROPAN-2-YL)-2-(TETRAHYDRO-2H-PYRAN-4-YL)-1 H-IMIDAZO[4,5-C]QUINOLIN-7-YL)-3,5-DIMETHYLISOXAZOLE AND ITS USE AS BROMODOMAIN INHIBITOR

Filed 2014-02-10 · Granted · Patent 9067936 (2015-06-30) The official file ↗The patent and its PDF ↗ · Art unit 1625 · Examiner Heidi L Reese Easy · CPC A61K 31/4745 · GlaxoSmithKline LLC · GLAXOSMITHKLINE

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

5.4 mo

to disposition 16.6 mo

Statutes raised

112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.